Ascentage Pharma Group International’s Quiet Period Set To End on March 5th (NASDAQ:AAPG)

Ascentage Pharma Group International’s (NASDAQ:AAPG) quiet period is set to end on Wednesday, March 5th. Ascentage Pharma Group International had issued 7,325,000 shares in its public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. During the company’s quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Ascentage Pharma Group International Price Performance

Shares of NASDAQ:AAPG opened at $20.16 on Wednesday. Ascentage Pharma Group International has a 12-month low of $16.50 and a 12-month high of $21.40.

About Ascentage Pharma Group International

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.